| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.102 | 4.002 | 4.893 | 15.689 | 26.169 | 46.595 | 53.432 |
| Total Income - EUR | - | - | - | 1.102 | 4.002 | 4.893 | 15.689 | 26.169 | 46.595 | 53.432 |
| Total Expenses - EUR | - | - | - | 904 | 2.976 | 1.719 | 11.970 | 20.448 | 36.797 | 46.444 |
| Gross Profit/Loss - EUR | - | - | - | 198 | 1.026 | 3.174 | 3.719 | 5.721 | 9.798 | 6.988 |
| Net Profit/Loss - EUR | - | - | - | 165 | 905 | 3.027 | 3.248 | 5.324 | 9.402 | 6.481 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Shippudent Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 30 | 0 | 9.297 | 7.436 | 8.878 | 4.709 | 4.276 |
| Current Assets | - | - | - | 2.283 | 8.193 | 11.450 | 9.368 | 6.538 | 18.056 | 15.988 |
| Inventories | - | - | - | 2.160 | 8.128 | 11.393 | 9.313 | 5.131 | 3.436 | 2.119 |
| Receivables | - | - | - | 54 | 53 | 0 | 0 | 277 | 50 | 0 |
| Cash | - | - | - | 69 | 12 | 57 | 56 | 1.131 | 14.570 | 13.869 |
| Shareholders Funds | - | - | - | 208 | 1.109 | 4.115 | 7.272 | 12.618 | 21.982 | 18.288 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.105 | 7.083 | 16.631 | 9.532 | 2.798 | 784 | 1.976 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Shippudent Laboratory S.r.l.